Alnylam Pharmaceuticals, Inc.

Polymer Capital Management (HK) LTD ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

36,765

Value ($000)

14,620

Weight

2.3%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	14,620	2.3%	36,765	12/31/2025
2025 Q3	11/14/2025	13,178	1.8%	28,900	9/30/2025
2025 Q2	8/14/2025	9,414	1.5%	28,869	6/30/2025